Skip to main content
. Author manuscript; available in PMC: 2008 Apr 5.
Published in final edited form as: Regul Pept. 2006 Dec 28;140(1-2):12–20. doi: 10.1016/j.regpep.2006.11.020

Figure 3.

Figure 3

Kallikrein infusion reduces monocyte/macrophage accumulation and the expression of pro-inflammatory mediators in the infarcted myocardium. (A) Representative images of ED-1 immunostaining in the infarcted area. Original magnification is 200×. (B) Quantitative analysis of ED-1-positive cells. (C) Representative Western blots of cardiac VCAM-1 levels. (D) Relative VCAM-1 and (E) MCP-1 mRNA levels determined by real-time PCR. Values are expressed as mean ± SEM (n=6–7, *P<0.05 vs. MI & MI/TK+Icatibant).